EFTA00682061.pdf

DataSet-9 2 pages 580 words document
👁 1 💬 0
📄 Extracted Text (580 words)
From: "McCaffrey, Carlyn" To: Jeffrey Epstein <[email protected]> CC: "Kirschner, Elyse" Subject: RE: Re: Date: Wed, 03 Apr 2013 02:51:13 +0000 If we decant the 97 trust into a new trust before the Judah Trust ends, the Independent Trustees can amend the Judah Trust so that its profits are distributed to the same trust that has received the assets of the 97 Trust. Carlyn S. McCaffrey I Partner McDermott Will & Emery LLP I 340 Madison Avenue, New York, NY 10173 4I From: Jeffrey Epstein prialito Sent: Tuesday, April 02, 2013 6:52 AM To: McCaffrey, Carlyn Subject: Re: thanks as always .. also as the judah trust currently pours into the 97 trust ? , would you find it more reasonbale to restate or decant after that event or can we make many amendments before aug. I thought tha might open up the old later on? On Tue, Apr 2, 2013 at 6:49 AM, McCaffrey, Carlyn > wrote: No - What you're describing is a purchase of the 8FP interests for a note secured by the art. That's not a sale of the art. Carlyn S. McCaffrey I Partner cDermott Will & Emery LLP 340 Madison Avenue, New York, NY 10173 From: Jeffrey Epstein (malitore gmLmin Sent: Monday, April 01, 2013 11:00 PM To: McCaffrey, Carlyn Subject: would you see anything wrong with leon substituing a collateral note for the stock held by the trust. if the art was collateral for expample? The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00682061 ******************************************************************************************************************* IRS Circular 230 Disclosure: To comply with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained herein (including any attachments), unless specifically stated otherwise, is not intended or written to be used, and cannot be used, for the purposes of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter herein. This message is a PRIVILEGED AND CONFIDENTIAL communication. This message and all attachments are a private communication sent by a law firm and may be confidential or protected by privilege. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution or use of the information contained in or attached to this message is strictly prohibited. Please notify the sender of the delivery error by replying to this message, and then delete it from your system. Thank you. ********************************** ************ ***************************** *********************************** ***** Please visit for more information about our Firm. The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of Jeffrey Epstein Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00682062
ℹ️ Document Details
SHA-256
84f659fd04e83173e09b77c2d852a254fe243ca91aa7f871d0dd9105b243a3dd
Bates Number
EFTA00682061
Dataset
DataSet-9
Type
document
Pages
2

Community Rating

Sign in to rate this document

📋 What Is This?

Loading…
Sign in to add a description

💬 Comments 0

Sign in to join the discussion
Loading comments…
Link copied!